Worth reading
76Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
10
％（次期売上高の当期比）Wording
Avoiding a definitive answer
How definitive the wording is.Revised forecast
Next period · Full yearNet Sales—→1,270hundred million
—
Operating profit—→126hundred million
—
Ordinary income—→128hundred million
—
Profit attributable to owners of the parent—→92hundred million
—
The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Reason for the revision
受注残や半導体需要の拡大などにより増収を見込む一方、人的投資・DX推進による固定費増、インフレによる原材料価格上昇、他社製品比率上昇による原価率悪化により減益を見込む。
Details and amount of extraordinary loss
固定資産売却損11百万円、固定資産処分損13百万円、災害による損失42百万円、災害損失引当金繰入額116百万円（特別損失合計183百万円）
Previous-period results売上高1,154億34百万円、営業利益133億82百万円、経常利益135億59百万円、親会社株主に帰属する当期純利益97億81百万円
Dividend forecast revision当期末配当は1株90円（中間配当30円、期末配当60円）を予定。次期年間配当は1株90円（中間配当45円、期末配当45円）を予定。
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥1,270 hundred million（10.0％増（当期比）） |
| Operating profit | Not disclosed → ¥126 hundred million（5.8％減（当期比）） |
| Ordinary income | Not disclosed → ¥128 hundred million（5.6％減（当期比）） |
| Profit attributable to owners of the parent | Not disclosed → ¥92 hundred million（5.9％減（当期比）） |
| Fiscal Period Covered | Next period |
| Period Covered | Full year |
| Previous-period results | 売上高1,154億34百万円、営業利益133億82百万円、経常利益135億59百万円、親会社株主に帰属する当期純利益97億81百万円 |
| Reason for the revision | 受注残や半導体需要の拡大などにより増収を見込む一方、人的投資・DX推進による固定費増、インフレによる原材料価格上昇、他社製品比率上昇による原価率悪化により減益を見込む。 |
| Details and amount of extraordinary loss | 固定資産売却損11百万円、固定資産処分損13百万円、災害による損失42百万円、災害損失引当金繰入額116百万円（特別損失合計183百万円） |
| Dividend forecast revision | 当期末配当は1株90円（中間配当30円、期末配当60円）を予定。次期年間配当は1株90円（中間配当45円、期末配当45円）を予定。 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
Net income per sharePublication date of previous forecast
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.次期は、飲料用無菌充填ラインや注射薬バイアル充填ラインの受注残、AI普及に伴う半導体需要の拡大、農業関連の補助事業継続などにより増収を見込む。一方、人的投資・DX推進による固定費増、素材・エネルギー価格を中心としたインフレによる原材料価格上昇、他社製品比率上昇による原価率悪化により減益を見込む。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.